GILEAD (GILD) Bɛn Dɛŋɛn Akɔc
Gilead Sciences
Bɛ̈ny cɔk aya$150.95Aciic 25 Sep 2026 19:59 UTC
Change+0.90%
AI forecast: GILD
AI ekek aŋok wɛlɛɛl bɛn bɛn lɔŋɔŋ, bɛn bɛn cɔlɔŋ, kɛ bɛn bɛn cɔlɔŋ. Cɔkɔkɔkɔ cɔlɔŋ bɛn bɛn lɔŋɔŋ. Aŋok wɛlɛɛl aŋok wɛlɛɛl, aŋok wɛlɛɛl aŋok wɛlɛɛl.
Bɛn cɔk ɛcɔk 6
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nyɛn cɔk aya bɛn
Ditëëk ë bɛ̈ɛ̈r ë cë lɔ – ditëëk ë cë lɔ kee aköl aköl ë bɛ̈ɛ̈r ë cë lɔ – aye Premium.
Unlock PremiumBɛn kɔc ke bɛn
Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic agents to improve care for patients with life-threatening diseases. The company’s key areas of focus include HIV, AIDS, liver diseases, and serious cardiovascular and respiratory conditions.
